UPDATED Jun 20, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SNDX | US$19.27 | 1.1% | -9.6% | US$1.6b | US$34.33 | PB3.3x | E22.9% | n/a | ||
ADPT | US$3.20 | 3.9% | -55.7% | US$453.9m | US$6.33 | PS2.7x | E19.5% | n/a | ||
ARCT | US$26.59 | 2.4% | 8.0% | US$699.2m | US$74.75 | PS5.8x | E63.5% | n/a | ||
CRVO | US$21.40 | 10.1% | n/a | US$160.4m | US$55.00 | PS21.8x | E-49.0% | n/a | ||
CTNM | US$19.68 | 3.3% | n/a | US$490.0m | US$28.00 | PS10.1x | S-76.1% | n/a | ||
PBH | US$65.28 | 0.5% | 14.5% | US$3.2b | US$73.50 | PE15.6x | E4.7% | n/a | ||
SCLX | US$1.96 | 7.1% | -71.0% | US$221.7m | US$5.33 | PS5x | E22.2% | n/a | ||
ENGN | US$8.71 | 4.2% | -18.6% | US$369.2m | US$33.00 | PB1.6x | E2.5% | n/a | ||
RCKT | US$20.85 | 0.8% | -3.3% | US$1.9b | US$50.08 | PB4.3x | E57.3% | n/a | ||
TCRX | US$7.23 | 4.2% | 155.5% | US$366.9m | US$12.29 | PS25.8x | E-8.1% | n/a | ||
ARQT | US$8.28 | 1.6% | -10.8% | US$943.5m | US$19.00 | PS9x | E66.3% | n/a | ||
NAUT | US$2.53 | 5.0% | -34.5% | US$301.9m | US$3.58 | PB1.3x | E-20.0% | n/a | ||
PEPG | US$16.80 | 2.7% | 74.8% | US$530.3m | US$21.60 | PB3x | E24.2% | n/a | ||
EPIX | US$4.98 | 6.9% | 71.7% | US$206.7m | US$19.56 | PB1.7x | E-12.4% | n/a | ||
REPL | US$7.87 | 3.0% | -66.5% | US$469.2m | US$14.33 | PB1.3x | E22.9% | n/a | ||
ANNX | US$5.20 | 2.6% | 43.6% | US$534.4m | US$15.67 | PB2.1x | E31.6% | n/a | ||
VRDN | US$12.38 | 1.6% | -53.6% | US$777.4m | US$35.19 | PS2743.5x | E48.3% | n/a | ||
YMTX | US$13.23 | 8.6% | -41.3% | US$143.6m | n/a | PS29.7x | n/a | n/a | ||
BMEA | US$5.19 | 7.0% | -84.1% | US$174.3m | US$24.43 | PB1.4x | E5.4% | n/a | ||
AGEN | US$13.57 | 4.5% | -61.9% | US$272.8m | US$44.25 | PS1.8x | E10.3% | n/a | ||
OTLK | US$7.59 | 7.4% | -78.1% | US$165.5m | US$38.43 | PE-1.1x | E67.5% | n/a | ||
VIGL | US$4.19 | 8.3% | -58.1% | US$145.5m | US$16.75 | PB1.5x | E17.2% | n/a | ||
ELYM | US$7.75 | 5.4% | 159.2% | US$218.7m | n/a | PB2.2x | n/a | n/a | ||
HZNP | US$116.30 | 0.04% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a |